Co-Diagnostics announces closing of $7M registered direct offering

Co-Diagnostics (CODX) announced the closing of its previously announced offering of 12,727,272 shares of common stock at an offering price of 55c per share. The gross proceeds to the company from the Offering were approximately $7M before deducting the placement agent’s fees and other offering expenses. The company intends to use proceeds from the Offering for working capital and general corporate purposes. Maxim Group LLC acted as the sole placement agent in connection with the Offering.